STMC-106

N/A

Report date: 2024/03/22 15:52:08

Base Information

Drug NameSTMC-106
Drug Alias NameSTMC-106
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsEnterocolitis, Necrotizing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSiolta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSiolta Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsEnterocolitis, Necrotizing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A